» Articles » PMID: 2843816

The 5' Flanking Region of the Gene for the Epstein-Barr Virus-encoded Nuclear Antigen 2 Contains a Cell Type Specific Cis-acting Regulatory Element That Activates Transcription in Transfected B-cells

Overview
Specialty Biochemistry
Date 1988 Sep 12
PMID 2843816
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

We have recently identified the promoter that positions the initiation (cap) site for RNA encoding the Epstein-Barr virus (EBV) determined nuclear antigen 2 (EBNA2) in transfected COS-1 cells. The cells were transfected with recombinant vectors that contained the BamHI WYH region of the EBV genome. In order to delineate regulatory DNA sequences required for the expression of EBNA2 the 5' flanking region of the gene was linked to reporter genes in expression vectors and transfected into EBV genome-negative lymphoid DG75 cells. We demonstrate that several cis-acting elements contribute to a transcriptional enhancer activity found in the region between nucleotides-553 and -86 relative to the cap site. The enhancer was active in lymphoid DG75 cells but not in HeLa cells and stimulated transcription also from the heterologous thymidine kinase (TK) and beta-globin promoters. Nuclear extracts of lymphoid cells contained protein factors that bound to the enhancer. The in vitro introduction of a mutation in the enhancer sequence that substantially reduced the transcription stimulatory activity concurrently blocked the binding of one of the factors.

Citing Articles

Nuclear factor-kappaB binds to the Epstein-Barr Virus LMP1 promoter and upregulates its expression.

Johansson P, Jansson A, Ruetschi U, Rymo L J Virol. 2008; 83(3):1393-401.

PMID: 19019967 PMC: 2620919. DOI: 10.1128/JVI.01637-08.


Epstein-Barr virus exploits BSAP/Pax5 to achieve the B-cell specificity of its growth-transforming program.

Tierney R, Nagra J, Hutchings I, Shannon-Lowe C, Altmann M, Hammerschmidt W J Virol. 2007; 81(18):10092-100.

PMID: 17626071 PMC: 2045388. DOI: 10.1128/JVI.00358-07.


Role of a consensus AP-2 regulatory sequence within the Epstein-Barr virus LMP1 promoter in EBNA2 mediated transactivation.

Jansson A, Johansson P, Yang W, Palmqvist L, Sjoblom-Hallen A, Rymo L Virus Genes. 2007; 35(2):203-14.

PMID: 17546492 DOI: 10.1007/s11262-007-0116-x.


Functional interaction of nuclear factor y and sp1 is required for activation of the epstein-barr virus C promoter.

Borestrom C, Zetterberg H, Liff K, Rymo L J Virol. 2002; 77(2):821-9.

PMID: 12502798 PMC: 140792. DOI: 10.1128/jvi.77.2.821-829.2003.


Deletion of Epstein-Barr virus regulatory sequences upstream of the EBNA gene promoter Wp1 is unfavorable for B-Cell immortalization.

Yoo L, Woloszynek J, Templeton S, Speck S J Virol. 2002; 76(22):11763-9.

PMID: 12388739 PMC: 136791. DOI: 10.1128/jvi.76.22.11763-11769.2002.


References
1.
Neuberger M . Expression and regulation of immunoglobulin heavy chain gene transfected into lymphoid cells. EMBO J. 1983; 2(8):1373-8. PMC: 555285. DOI: 10.1002/j.1460-2075.1983.tb01594.x. View

2.
Svensson C, Akusjarvi G . Adenovirus VA RNAI mediates a translational stimulation which is not restricted to the viral mRNAs. EMBO J. 1985; 4(4):957-64. PMC: 554285. DOI: 10.1002/j.1460-2075.1985.tb03724.x. View

3.
Graham F, Van Der Eb A . A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973; 52(2):456-67. DOI: 10.1016/0042-6822(73)90341-3. View

4.
Miller G, Robinson J, Heston L, Lipman M . Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference. Proc Natl Acad Sci U S A. 1974; 71(10):4006-10. PMC: 434316. DOI: 10.1073/pnas.71.10.4006. View

5.
Menezes J, Leibold W, Klein G . Biological differences between Epstein-Barr virus (EBV) strains with regard to lymphocyte transforming ability, superinfection and antigen induction. Exp Cell Res. 1975; 92(2):478-84. DOI: 10.1016/0014-4827(75)90404-8. View